The Rice bioengineering department helped host the annual meeting of the American Institute for Medical and Biological ...

The University of Florida Institute of Food and Agricultural Sciences (UF/IFAS) Department of Agricultural and Biological ...

The Department of Chemical and Biological Engineering at Northwestern University is pioneering transformational discoveries in synthetic biology, biotechnology, catalysis, medicine, complex systems, ...

Anand Ramamurthi, the Peter C. Rossin Professor of Bioengineering and chair of the Department of Bioengineering at Lehigh University, and pioneer in regenerative technologies for non-invasive tissue ...

FIU professors Angela Laird and Jorge Riera Diaz were recently inducted into the 2024 Class of the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows. Election to the ...

The Department of Chemical and Biological Engineering is updating one of its undergraduate majors to offer students greater flexibility in exploring biological engineering-focused courses. Starting in ...

Chemical engineer Haiqing Lin was recognized for his design, discovery and development of high-performance membrane materials for carbon dioxide capture by the American Institute of Chemical Engineers ...

Karin Wuertz-Kozak, a faculty researcher at Rochester Institute of Technology, was recently inducted into the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows.

Jaideep Vaidya, a distinguished professor at Rutgers Business School, was recently inducted by the American Institute for Medical and Biological Engineering (AIMBE) to its College of Fellows. The ...

We will conduct innovative research that provides new fundamental knowledge and addresses societal challenges. We conduct impactful chemical and biological engineering research that addresses societal ...

The discipline of Catalysis and Reaction Engineering (CRE) seeks to control and understand the networks of reactions that occur in ‘reactors’ ranging from cellular compartments up to world-scale ...

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir (LEN), a groundbreaking twice-yearly injectable HIV-1 capsid inhibitor for ...